Lihe Biomedical Technology Overview
- Founded
- 2014
- Status
- Private
- Latest Deal Type
- Early Stage VC
- Investors
- 2
Lihe Biomedical Technology General Information
Description
Developer of biosynthesis and green chemical technology intended for biomedicine. The company develops biomedicine in a sustainable way that replaces traditional chemical production processes with biosynthesis and green chemical technology, greatly accelerating green manufacturing and improving production efficiency by reducing the use of flammable, explosive and toxic drugs and the emissions of chemical wastes.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
- Room E302, E306, 5th Floor, Building B8, Bio-Industry (Jiufeng) Innovation Base
- No. 666 Gaoxin Avenue, East Lake New Technology Development Zone
- Wuhan, Hubei
- China
Lihe Biomedical Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 30-Jun-2018 | Completed | Generating Revenue |
Lihe Biomedical Technology Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Fan Peng | Chief Executive Officer & Founder |
Lihe Biomedical Technology Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Donghu Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Wuhan Optics Valley Elite Investment Management | Venture Capital | Minority | 000 0000 | 000000 0 |